Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Apolipoprotein-A1 transports and regulates MMP2 in the blood.

Nature communications·2025

Same author

Ionically-crosslinked carboxymethyl chitosan scaffolds by additive manufacturing for antimicrobial wound dressing applications.

Carbohydrate polymers·2024

Same author

A self-reinforcing cycle hypothesis in heart failure pathogenesis.

Nature cardiovascular research·2024

Same author

Wet-Spun Chitosan-Sodium Caseinate Fibers for Biomedicine: From Spinning Process to Physical Properties.

International journal of molecular sciences·2024

Same author

Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens.

Frontiers in bioengineering and biotechnology·2023

Same author

Lipid nanoparticles containing coenzyme Q10 for topical applications: An overview of their characterization.

Colloids and surfaces. B, Biointerfaces·2023

Search research articles

Related Experiment Video

Updated: May 20, 2026

Generation of Alginate Microspheres for Biomedical Applications

Generation of Alginate Microspheres for Biomedical Applications

Published on: August 12, 2012

Microencapsulation of alpha interferons in biodegradable microspheres.

Vivian Saez¹, José Ramón, Carlos Peniche

¹Formulation Development Department, Center for Genetic Engineering and Biotechnology, Havana, Cuba.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research

|July 11, 2012

Summary

Biodegradable microspheres offer a novel delivery system for interferon alpha (IFN-α), potentially reducing frequent injections and improving patient outcomes. This review details microsphere production, characterization, and clinical applications.

More Related Videos

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

Related Experiment Videos

Last Updated: May 20, 2026

Generation of Alginate Microspheres for Biomedical Applications

Generation of Alginate Microspheres for Biomedical Applications

Published on: August 12, 2012

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

Area of Science:

Biotechnology
Drug Delivery Systems
Immunology

Background:

Interferons alpha (IFN-α) possess significant immunomodulatory, antiproliferative, and antiviral properties, making them valuable in clinical settings.
Current injectable IFN-α formulations require frequent administration and can cause adverse reactions, limiting their therapeutic utility.
Biodegradable microspheres present a promising alternative for sustained IFN-α delivery, potentially mitigating these limitations.

Purpose of the Study:

To review the technology of encapsulating IFN-α into biodegradable microspheres.
To detail methods for microsphere preparation and characterization.
To provide an overview of preclinical and clinical studies involving IFN-α-loaded microspheres.

Main Methods:

Description of methods and parameters for producing IFN-α-loaded microspheres.
Characterization techniques including morphology, particle size, loading efficiency, residual water/solvent content, release profile, and sterility testing.
Assessment of encapsulated IFN-α integrity and stabilization during microencapsulation.

Main Results:

Established methods for creating IFN-α-loaded microspheres with defined characteristics.
Comprehensive data on microsphere properties and drug release kinetics.
Evaluation of IFN-α stability and protective strategies within the microsphere matrix.

Conclusions:

IFN-α-loaded microspheres represent an advanced drug delivery system with potential to improve IFN-α therapy.
The technology offers a viable strategy to overcome limitations of conventional IFN-α administration.
Further preclinical and clinical investigations support the therapeutic potential of this innovative approach.